LafargeHolcim Bangladesh PLC. (DSE:LHB)
Bangladesh · Delayed Price · Currency is BDT 59.50
-0.40 (-0.67%)
At close: Aug 6, 2025
Theseus Pharmaceuticals Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 28,105 | 27,543 | 28,388 | 23,594 | 20,534 | 16,222 | Upgrade | |
Revenue Growth (YoY) | 2.01% | -2.98% | 20.32% | 14.90% | 26.58% | -9.07% | Upgrade |
Cost of Revenue | 20,227 | 19,298 | 18,119 | 15,260 | 13,894 | 11,616 | Upgrade |
Gross Profit | 7,879 | 8,245 | 10,269 | 8,334 | 6,640 | 4,606 | Upgrade |
Selling, General & Admin | 2,524 | 2,395 | 2,614 | 2,396 | 1,955 | 1,687 | Upgrade |
Other Operating Expenses | -114.01 | -117.52 | -100.7 | -44.62 | -133.32 | -14.62 | Upgrade |
Operating Expenses | 2,410 | 2,278 | 2,514 | 2,352 | 1,822 | 1,672 | Upgrade |
Operating Income | 5,469 | 5,967 | 7,756 | 5,982 | 4,818 | 2,934 | Upgrade |
Interest Expense | - | -6.3 | -7.56 | -6.74 | -2.37 | -53.37 | Upgrade |
Interest & Investment Income | 476.01 | 178.69 | 167.74 | 49.17 | 26.73 | 18.68 | Upgrade |
Currency Exchange Gain (Loss) | -375.68 | -375.68 | -117.82 | -238.64 | -5.24 | -36.98 | Upgrade |
Other Non Operating Income (Expenses) | -115.11 | -115.11 | -83.69 | -30.56 | -12.39 | -19.61 | Upgrade |
EBT Excluding Unusual Items | 5,454 | 5,649 | 7,714 | 5,756 | 4,825 | 2,842 | Upgrade |
Gain (Loss) on Sale of Assets | -90.19 | -90.19 | 1.98 | -12.02 | 2.73 | 6.45 | Upgrade |
Pretax Income | 5,364 | 5,558 | 7,716 | 5,744 | 4,828 | 2,849 | Upgrade |
Income Tax Expense | 1,617 | 1,739 | 1,775 | 1,299 | 945.82 | 487.39 | Upgrade |
Earnings From Continuing Operations | 3,747 | 3,819 | 5,942 | 4,445 | 3,882 | 2,361 | Upgrade |
Minority Interest in Earnings | 0.02 | 0.02 | 0.37 | 0.03 | 0.03 | 0.02 | Upgrade |
Net Income | 3,747 | 3,819 | 5,942 | 4,445 | 3,882 | 2,361 | Upgrade |
Net Income to Common | 3,747 | 3,819 | 5,942 | 4,445 | 3,882 | 2,361 | Upgrade |
Net Income Growth | -21.24% | -35.73% | 33.69% | 14.49% | 64.39% | 35.91% | Upgrade |
Shares Outstanding (Basic) | 1,161 | 1,161 | 1,161 | 1,161 | 1,161 | 1,161 | Upgrade |
Shares Outstanding (Diluted) | 1,161 | 1,161 | 1,161 | 1,161 | 1,161 | 1,161 | Upgrade |
EPS (Basic) | 3.23 | 3.29 | 5.12 | 3.83 | 3.34 | 2.03 | Upgrade |
EPS (Diluted) | 3.23 | 3.29 | 5.12 | 3.83 | 3.34 | 2.03 | Upgrade |
EPS Growth | -21.28% | -35.73% | 33.69% | 14.58% | 64.53% | 35.69% | Upgrade |
Free Cash Flow | 5,550 | 6,694 | 7,549 | 5,992 | 5,131 | 3,766 | Upgrade |
Free Cash Flow Per Share | 4.78 | 5.76 | 6.50 | 5.16 | 4.42 | 3.24 | Upgrade |
Dividend Per Share | 3.800 | 3.800 | 5.000 | 4.800 | 2.500 | 1.000 | Upgrade |
Dividend Growth | -24.00% | -24.00% | 4.17% | 92.00% | 150.00% | - | Upgrade |
Gross Margin | 28.03% | 29.94% | 36.18% | 35.32% | 32.34% | 28.39% | Upgrade |
Operating Margin | 19.46% | 21.66% | 27.32% | 25.36% | 23.46% | 18.08% | Upgrade |
Profit Margin | 13.33% | 13.87% | 20.93% | 18.84% | 18.90% | 14.56% | Upgrade |
Free Cash Flow Margin | 19.75% | 24.30% | 26.59% | 25.40% | 24.99% | 23.21% | Upgrade |
EBITDA | 6,802 | 7,268 | 9,012 | 7,314 | 6,075 | 3,953 | Upgrade |
EBITDA Margin | 24.20% | 26.39% | 31.75% | 31.00% | 29.59% | 24.37% | Upgrade |
D&A For EBITDA | 1,333 | 1,301 | 1,256 | 1,332 | 1,257 | 1,020 | Upgrade |
EBIT | 5,469 | 5,967 | 7,756 | 5,982 | 4,818 | 2,934 | Upgrade |
EBIT Margin | 19.46% | 21.66% | 27.32% | 25.36% | 23.46% | 18.08% | Upgrade |
Effective Tax Rate | 30.15% | 31.29% | 23.00% | 22.62% | 19.59% | 17.11% | Upgrade |
Advertising Expenses | - | 365.89 | 249.78 | 341.29 | 234.69 | 175.89 | Upgrade |
Updated Oct 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.